| Product Code: ETC7539468 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Cell And Gene Therapy Manufacturing Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Cell And Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 India Cell And Gene Therapy Manufacturing Market - Industry Life Cycle |
3.4 India Cell And Gene Therapy Manufacturing Market - Porter's Five Forces |
3.5 India Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 India Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Scale, 2021 & 2031F |
3.7 India Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Mode, 2021 & 2031F |
3.8 India Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
4 India Cell And Gene Therapy Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders and chronic diseases in India |
4.2.2 Growing government initiatives and funding to support cell and gene therapy research and manufacturing |
4.2.3 Rising investments from domestic and international pharmaceutical companies in cell and gene therapy manufacturing facilities in India |
4.3 Market Restraints |
4.3.1 High cost associated with cell and gene therapy manufacturing processes |
4.3.2 Lack of skilled workforce proficient in cell and gene therapy manufacturing technologies in India |
4.3.3 Stringent regulatory requirements and approval processes for cell and gene therapy products in the Indian market |
5 India Cell And Gene Therapy Manufacturing Market Trends |
6 India Cell And Gene Therapy Manufacturing Market, By Types |
6.1 India Cell And Gene Therapy Manufacturing Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 India Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Therapy Type, 2021- 2031F |
6.1.3 India Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell therapy manufacturing, 2021- 2031F |
6.1.4 India Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Gene therapy manufacturing, 2021- 2031F |
6.2 India Cell And Gene Therapy Manufacturing Market, By Scale |
6.2.1 Overview and Analysis |
6.2.2 India Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Pre-commercial/R&D scale manufacturing, 2021- 2031F |
6.2.3 India Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Commercial scale manufacturing, 2021- 2031F |
6.3 India Cell And Gene Therapy Manufacturing Market, By Mode |
6.3.1 Overview and Analysis |
6.3.2 India Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Contract manufacturing, 2021- 2031F |
6.3.3 India Cell And Gene Therapy Manufacturing Market Revenues & Volume, By In-house manufacturing, 2021- 2031F |
6.4 India Cell And Gene Therapy Manufacturing Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 India Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell processing, 2021- 2031F |
6.4.3 India Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell banking, 2021- 2031F |
6.4.4 India Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Process development, 2021- 2031F |
6.4.5 India Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Fill & finish operations, 2021- 2031F |
6.4.6 India Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Analytical and quality testing, 2021- 2031F |
6.4.7 India Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Raw material testing, 2021- 2031F |
6.4.8 India Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
6.4.9 India Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
7 India Cell And Gene Therapy Manufacturing Market Import-Export Trade Statistics |
7.1 India Cell And Gene Therapy Manufacturing Market Export to Major Countries |
7.2 India Cell And Gene Therapy Manufacturing Market Imports from Major Countries |
8 India Cell And Gene Therapy Manufacturing Market Key Performance Indicators |
8.1 Number of research grants and funding allocated by the government for cell and gene therapy manufacturing projects |
8.2 Percentage increase in the number of cell and gene therapy manufacturing facilities being set up in India |
8.3 Average time taken for regulatory approval of cell and gene therapy products in India |
9 India Cell And Gene Therapy Manufacturing Market - Opportunity Assessment |
9.1 India Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 India Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Scale, 2021 & 2031F |
9.3 India Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Mode, 2021 & 2031F |
9.4 India Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
10 India Cell And Gene Therapy Manufacturing Market - Competitive Landscape |
10.1 India Cell And Gene Therapy Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 India Cell And Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here